# PD-L1 expression and tumor mutational burden status for prediction of response to chemotherapy and targeted therapy in non-small cell lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pd-l1-expression-and-tumor-mutational-burden-status-for-prediction-of-response/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yanhui Chen,Quanxing Liu,Zhiming Chen,Yating Wang,Wanning Yang,Ying Hu,Wenbo Han,Hui Zeng,Haitao Ma,Jigang Dai,Henghui Zhang |
| Citations | 109 |
| DOI | 10.1186/s13046-019-1192-1 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://jeccr.biomedcentral.com/track/pdf/10.1186/s13046-019-1192-1 |
| OpenAlex ID | https://openalex.org/W2944817662 |
| PMID | 31088500 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Ying Hu](https://scholariq.org/researchers/ying-hu-2/)

## Paper journal

- [Journal of Experimental & Clinical Cancer Research](https://scholariq.org/journals/journal-of-experimental-and-clinical-cancer-research/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.